Robin Wright - 10 May 2024 Form 4 Insider Report for Barinthus Biotherapeutics plc. (BRNS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRNS	Share Option (Right to Buy)	Award	$0	+19,516		$0.000000	19,516	10 May 2024	Ordinary Shares	19,516	$2.34	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
F2	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.